Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
What is polypharmacy? A systematic review of definitions
2017 Standout
Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
2012
Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure
2009
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
2014
N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure
2010
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
2004
First hospitalization for heart failure in France in 2009: Patient characteristics and 30-day follow-up
2013
Estimated glomerular filtration rate is an independent predictor for mortality of patients with acute heart failure
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Ruling out cardiac failure: Cost-benefit analysis of a sequential testing strategy with NT-proBNP before echocardiography
2012 StandoutNobel
Coronary angiography through the radial or the femoral approach: The CARAFE study
2001
Cardiac manifestation of the hypereosinophilic syndrome: new insights
2010
B-Type Natriuretic Peptide–Guided Heart Failure Therapy
2010
Changes of Natriuretic Peptides Predict Hospital Admissions in Patients With Chronic Heart Failure
2014
Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets
2010
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
2012
Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events
2008
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials
2008 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
The Role of Stress Echocardiography in Valvular Heart Disease: A Current Appraisal
2017 Standout
The Diagnostic Utility of Cardiac Biomarkers in Dialysis Patients
2012
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
Usefulness of B-type Natriuretic Peptide Levels in Predicting Hemodynamic and Clinical Decompensation
2009
Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes
2011
Transradial cardiac procedures: the state of the art
2010
Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death
2002
Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison
1999
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
Stenting in chronic coronary occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty
1996
Use of Novel and Conventional Biomarkers for Management of Patients With Heart Failure
2011
Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate
2004
Cardiorenal Syndrome
2008 Standout
The Serotonin Syndrome
2005 Standout
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
2016
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology
2013
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
BNP-Guided vs Symptom-Guided Heart Failure Therapy
2009
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes
2014
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures
2004 Standout
The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
2016
Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de Pointes
2010
Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis
2016
Glutamate synthase: structural, mechanistic and regulatory properties, and role in the amino acid metabolism
2005 StandoutNobel
The Transradial Approach to Percutaneous Coronary Intervention
2010
Transradial coronary intervention in Japanese patients
1999
Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials
2014
The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure
2011
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
2009
PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
2013
Third Universal Definition of Myocardial Infarction
2012 Standout
Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction
2017
Profiles of Serial Changes in Cardiac Troponin T Concentrations and Outcome in Ambulatory Patients With Chronic Heart Failure
2009
The effect of altering heart rate on ventricular function in patients with heart failure treated with β-blockers
2006
Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials
2013
N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure
2009
Comparison of bivalirudin versus heparin on radial artery occlusion after transradial catheterization
2010
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure
2014
Biomarkers in Heart Failure
2008 Standout
Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity
2008
B-type Natriuretic Peptide-guided Chronic Heart Failure Therapy: A Meta-analysis of 11 Randomised Controlled Trials
2013
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
2019 Standout
Brain natriuretic peptide‐guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome
2011
Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study
2009
Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure)
2010
Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care
2011
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Plasma B-Type Natriuretic Peptide Levels Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
2004
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019
Radial Artery Occlusion After Transradial Interventions: A Systematic Review and Meta‐Analysis
2016
Biological functions of asparagine synthetase in plants
2010 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II)
2009
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
Works of F Funck being referenced
Left radial approach for coronary angiography: Results of a prospective study
1996
Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure
2007
Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol
2002
Short‐term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study
2002
Bedside B‐type natriuretic peptide and functional capacity in chronic heart failure
2003
[Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
1997
731-5 Early Reocclusion After Successful Coronary Angioplasty of Chronic Total Occlusions
1995
[Citalopram and Torsades de Pointes. A case report].
2001
Impact of heart failure management unit on heart failure-related readmission rate and mortality
2010
[Hemodynamic effects on intravenous propafenone in hypertrophic myocardiopathy].
1988